WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Nima Zargari
Associate
Patents and Innovations
San Diego
nzargari@wsgr.com

D858-350-2253

Download vCard
Open PDF

Dr. Nima Zargari is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on the preparation and prosecution of patent applications in the fields of chemistry, pharmaceuticals, and biotechnology. Nima represents a diverse range of clients, including innovative start-ups and multinational corporations, across various sectors.

Nima received his Ph.D. from the University of Southern California, where he developed novel palladium-catalyzed synthetic methodologies and founded an unexpected, latent radical reaction of methane. He also served as a judicial extern to the Honorable S. James Otero in the U.S. District Court for the Central District of California.

Experience

Dr. Nima Zargari is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on the preparation and prosecution of patent applications in the fields of chemistry, pharmaceuticals, and biotechnology. Nima represents a diverse range of clients, including innovative start-ups and multinational corporations, across various sectors.

Nima received his Ph.D. from the University of Southern California, where he developed novel palladium-catalyzed synthetic methodologies and founded an unexpected, latent radical reaction of methane. He also served as a judicial extern to the Honorable S. James Otero in the U.S. District Court for the Central District of California.

Education
  • J.D., Loyola Law School, 2020Otto Kaus Award for Excellence in Legal Scholarship; Editor-in-Chief, Loyola of Los Angeles Entertainment Law Review
  • Ph.D., Chemistry, University of Southern California, 2016

    Environmental Studies & Alternative Energy Fellowship; Burg Foundation Teaching Fellowship

  • B.S., Biological Sciences and Chemistry, University of California, Irvine, 2009

    With Honors

Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., Loyola Law School, 2020Otto Kaus Award for Excellence in Legal Scholarship; Editor-in-Chief, Loyola of Los Angeles Entertainment Law Review
  • Ph.D., Chemistry, University of Southern California, 2016

    Environmental Studies & Alternative Energy Fellowship; Burg Foundation Teaching Fellowship

  • B.S., Biological Sciences and Chemistry, University of California, Irvine, 2009

    With Honors

Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office

Select Publications

    • "Nitrohydroxylation of Olefins with Nitric Acid Using Tridentate NHC–Amidate–Alkoxide Containing Palladium Catalysts," 61 Topics in Catalysis 630-635, 2018
    • "Carbon Dioxide Hydrogenation: Efficient Catalysis by an NHC-Amidate Pd(II) Complex," 58 Tetrahedron Letters 3330-3332, 2017
    • "Unexpected, Latent Radical Reaction of Methane Propagated by Trifluoromethyl Radicals," 81 Journal of Organic Chemistry 9820-9825, 2016
    • "Hydroalkenylation: Palladium Catalyzed Co-Dimerization of Unactivated Alkenes," 57 Tetrahedron Letters 815-818, 2016
    • "Conversion of Saccharides into Formic Acid using Hydrogen Peroxide and a Recyclable Palladium(II) Catalyst in Aqueous Alkaline Media at Ambient Temperatures," 17 Green Chemistry 2736-2740, 2015

Select Speaking Engagements

  • Guest Lecturer, “Intellectual Property in Biopharmaceutical R&D,” Chapman University School of Pharmacy, Drug Discovery and Development, December 1, 2025

  • Guest Lecturer, “Intellectual Property and Regulations,” Chapman University School of Pharmacy, Drug Discovery and Development, November 18, 2024
Insights

Select Publications

    • "Nitrohydroxylation of Olefins with Nitric Acid Using Tridentate NHC–Amidate–Alkoxide Containing Palladium Catalysts," 61 Topics in Catalysis 630-635, 2018
    • "Carbon Dioxide Hydrogenation: Efficient Catalysis by an NHC-Amidate Pd(II) Complex," 58 Tetrahedron Letters 3330-3332, 2017
    • "Unexpected, Latent Radical Reaction of Methane Propagated by Trifluoromethyl Radicals," 81 Journal of Organic Chemistry 9820-9825, 2016
    • "Hydroalkenylation: Palladium Catalyzed Co-Dimerization of Unactivated Alkenes," 57 Tetrahedron Letters 815-818, 2016
    • "Conversion of Saccharides into Formic Acid using Hydrogen Peroxide and a Recyclable Palladium(II) Catalyst in Aqueous Alkaline Media at Ambient Temperatures," 17 Green Chemistry 2736-2740, 2015

Select Speaking Engagements

  • Guest Lecturer, “Intellectual Property in Biopharmaceutical R&D,” Chapman University School of Pharmacy, Drug Discovery and Development, December 1, 2025

  • Guest Lecturer, “Intellectual Property and Regulations,” Chapman University School of Pharmacy, Drug Discovery and Development, November 18, 2024

Biological Sciences and Biotechnology

  • Biochemistry
  • Genetics
  • Molecular biology
  • PCR

Therapeutics and Drug Discovery

  • Drug conjugates based drug discovery
  • Drug delivery
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Catalysis
  • Chemical synthesis
  • Chemistry
  • Green chemistry
  • Organic chemistry
  • Organometallics
  • Polymers
  • Polymorph
  • Process chemistry

Miscellaneous

  • Design patent
  • Formulations
Technical Fluency

Biological Sciences and Biotechnology

  • Biochemistry
  • Genetics
  • Molecular biology
  • PCR

Therapeutics and Drug Discovery

  • Drug conjugates based drug discovery
  • Drug delivery
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Catalysis
  • Chemical synthesis
  • Chemistry
  • Green chemistry
  • Organic chemistry
  • Organometallics
  • Polymers
  • Polymorph
  • Process chemistry

Miscellaneous

  • Design patent
  • Formulations
Focus Areas
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises Arthrosi Therapeutics on on Patent Matters Related to its Acquisition by Sobi
On December 13, 2025, Sobi announced it has entered into a definitive agreement to acquire Arthrosi Therapeutics, Inc., a private late-stage biotechnology company focused on developing a next-generation treatment for gout. Sobi will pay $950 million upfront in cash and up to $550 million in cash in clinical, regulatory and sales milestones. Wilson Sonsini Goodrich & Rosati represented Arthrosi Therapeutics on patent matters related to the acquisition.
Learn More
Alerts
Department of Commerce Initiates Bayh-Dole Compliance Review and Asserts March-In Proceeding Targeting Harvard University Patents
Executive Summary
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.